Olema Pharmaceuticals, Inc. (OLMA)

NASDAQ: OLMA · Real-Time Price · USD

16.00

-5.55 (-25.75%)

At close: Mar 9, 2026, 4:00 PM EDT

16.25

+0.25 (1.56%)

After-hours: Mar 9, 2026, 7:59 PM EDT

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	35.26	139.48	68.54	23.7	13.81	338.55
Short-Term Investments	293.7	294.61	193.27	180.72	273.44	-
Cash & Short-Term Investments	328.96	434.09	261.81	204.42	287.25	338.55
Cash Growth	53.17%	65.80%	28.07%	-28.84%	-15.15%	497766.18%
Other Current Assets	5.37	4.39	4.71	4.48	3.44	3.59
Total Current Assets	334.33	438.47	266.51	208.9	290.69	342.14
Net Property, Plant & Equipment	18.12	12.51	10.43	6.75	5.26	0.59
Total Assets	352.45	450.98	276.95	215.65	295.95	342.72
Accounts Payable	3.47	4.46	2.7	0.37	0.02	0.72
Accrued Expenses	37.01	36.13	17.94	15.16	8.07	3.87
Current Portion of Leases	1.17	1.17	0.99	1.02	0.93	-
Total Current Liabilities	41.66	41.76	21.62	16.55	9.02	4.59
Long-Term Debt	3	-	-	-	-	-
Long-Term Leases	0.31	0.26	1.43	1.55	2.36	-
Total Long-Term Liabilities	3.31	0.26	1.43	1.55	2.36	-
Total Liabilities	44.97	42.02	23.05	18.1	11.38	4.59
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	858.45	843.92	559.18	408.33	388.9	371.23
Accumulated Other Comprehensive Income	0.53	0.14	0.35	-1.81	-0.15	-
Retained Earnings	-551.5	-435.11	-305.63	-208.98	-104.19	-33.09
Total Common Shareholders' Equity	307.49	408.96	253.9	197.55	284.57	338.14
Shareholders' Equity	307.49	408.96	253.9	197.55	284.57	338.14
Total Liabilities & Equity	352.45	450.98	276.95	215.65	295.95	342.72
Total Debt	4.48	1.43	2.42	2.57	3.29	0
Net Cash (Debt)	324.48	432.66	259.39	201.86	283.96	338.55
Net Cash Growth	-25.00%	66.80%	28.50%	-28.91%	-16.12%	497766.18%
Net Cash Per Share	4.03	7.37	5.73	5.05	7.18	48.22
Book Value	307.49	408.96	253.9	197.55	284.57	338.14
Book Value Per Share	3.81	6.96	5.61	4.94	7.20	48.16
Tangible Book Value	307.49	408.96	253.9	197.55	284.57	338.14
Tangible Book Value Per Share	3.81	6.96	5.61	4.94	7.20	48.16

Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q